Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:52 AM ET

Sponsor Check › Person

No photo found yet (own website and image search run after this page is viewed)

Jason G. Wild

Named as an officer, director or promoter on SEC Form D filings · NC, NY, PA, FL · Nov 3, 2010 → Mar 15, 2021

12deals (issuers)

$382.4Mreported sold

765investors

78Form D filings

2010–2021years on file

Follow this person Look further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:22 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Jason G. Wild is listed as an executive officer, director, and promoter on 78 SEC Form D filings by 12 issuers between Apr 2010 and Mar 2026. Largest by amount reported sold: JW Opportunities Fund, LLC (Miami Beach, FL — pooled investment fund — 2013–2026; $168.6M reported sold to 302 investors), JW Partners, LP (Miami Beach, FL — pooled investment fund — 2010–2026; $96M reported sold to 198 investors), JW Select Investments, LP (Miami Beach, FL — pooled investment fund — 2010–2025; $36.3M reported sold to 98 investors), Vensun Pharmaceuticals, Inc. (Yardley, PA — pharmaceuticals — 2012–2016; $19.5M reported sold to 15 investors), ARBOR PHARMACEUTICALS INC (Atlanta, Georgia (as filed: 2Q) — pharmaceuticals — 2010; $17.4M reported sold to 10 investors) and 7 more (all listed below).

What this means That is a lot of deals — 12 separate companies raised money with this person listed as executive officer, director, and promoter, over about 16 years. Across those companies the filings report $382.4M sold in total.

Listed alongside Jason Klarreich (10 shared filings), JW GP, LLC (6 shared filings, management entity), Edward Schutter (5 shared filings), Dhananjay G. Wadekar (4 shared filings), Hemanshu Pandya (4 shared filings) and 15 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jason. Each name links to their own page.

The issuers belong to 3 sponsor groups: Group linked by Jason G. Wild (5 issuers, $324.4M reported sold, 2010–2026), Jw Dealfund (3 issuers, $9.62M reported sold, 2010–2013) and Vensun Pharmaceuticals (2 issuers, $19.5M reported sold, 2011–2016).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared the newest 50 of 78 public filings for Jason G. Wild and found 19 differences, 4 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Jason G. Wild has not run yet — it is joining a line of 28,475 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

1 case: 1 dismissed

Jason H Wild v. Department of Defense dismissed

District Court, C.D. California · No. 8:13-cv-01288 · Filed Aug 22, 2013 · Closed Nov 25, 2013 · Nature of suit: 895 Freedom of Information Act of 1974

Role of Jason H Wild: Plaintiff · Outcome: Terminated 2013-11-25 — FJC Integrated Database disposition: Dismissed: other Docket on CourtListener ↗

same full name (rare in federal dockets); 2 people with this name in Form D filings; court in CA (not a filing state); middle initial differs

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:22 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Jason G. Wild..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:22 AM ET.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

19 differences found between the filings for Jason G. Wild — 4 worth asking about (compared the newest 50 of 78 filings on Oct 24, 2026; older filings not covered)

Worth asking · Jul 17, 2017 – Jan 29, 2018

Amount sold went down between filings — JW Opportunities Fund, Ltd.

The Jul 17, 2017 filing says $1,550,000 sold; the Jan 29, 2018 Form D/A says $1,350,000 sold — $200,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D/A (earlier) · Jul 17, 2017 ↗Form D/A (later) · Jan 29, 2018 ↗JW Opportunities Fund, Ltd. — PartnerFacts page ↗

Sources

Form D/A (earlier) · Jul 17, 2017 ↗ (Jul 17, 2017)
Form D/A (later) · Jan 29, 2018 ↗ (Jan 29, 2018)
JW Opportunities Fund, Ltd. — PartnerFacts page ↗ (Mar 15, 2024)

Worth asking · Jan 28, 2020 – Jan 28, 2021

Investor count went down between filings — JW Partners, LP

The Jan 28, 2020 filing reports 198 investors; the Jan 28, 2021 Form D/A reports 93 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D/A (earlier) · Jan 28, 2020 ↗Form D/A (later) · Jan 28, 2021 ↗JW Partners, LP — PartnerFacts page ↗

Sources

Form D/A (earlier) · Jan 28, 2020 ↗ (Jan 28, 2020)
Form D/A (later) · Jan 28, 2021 ↗ (Jan 28, 2021)
JW Partners, LP — PartnerFacts page ↗ (Mar 17, 2026)

Worth asking · Jan 28, 2020 – Jan 28, 2021

Investor count went down between filings — JW Opportunities Fund, Ltd.

The Jan 28, 2020 filing reports 10 investors; the Jan 28, 2021 Form D/A reports 8 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D/A (earlier) · Jan 28, 2020 ↗Form D/A (later) · Jan 28, 2021 ↗JW Opportunities Fund, Ltd. — PartnerFacts page ↗

Sources

Form D/A (earlier) · Jan 28, 2020 ↗ (Jan 28, 2020)
Form D/A (later) · Jan 28, 2021 ↗ (Jan 28, 2021)
JW Opportunities Fund, Ltd. — PartnerFacts page ↗ (Mar 15, 2024)

Worth asking · Jul 17, 2017 – Jan 29, 2018

Investor count went down between filings — JW Opportunities Fund, Ltd.

The Jul 17, 2017 filing reports 9 investors; the Jan 29, 2018 Form D/A reports 6 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D/A (earlier) · Jul 17, 2017 ↗Form D/A (later) · Jan 29, 2018 ↗JW Opportunities Fund, Ltd. — PartnerFacts page ↗

Sources

Form D/A (earlier) · Jul 17, 2017 ↗ (Jul 17, 2017)
Form D/A (later) · Jan 29, 2018 ↗ (Jan 29, 2018)
JW Opportunities Fund, Ltd. — PartnerFacts page ↗ (Mar 15, 2024)

Note · Jan 5, 2018

13% of the money raised went to insiders — Vitruvias Therapeutics, Inc.

The Jan 5, 2018 Form D/A reports $11,500,000 sold and $1,510,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate). Issuer's note: "Bryce Harvey owns the majority of interests in H2-Pharma,LLC, which loaned money to the issuer. $1,500,000 will be used to pay down principal of that loan. $10,000 will be used to pay H2 Pharma, offic".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D/A · Jan 5, 2018 ↗Vitruvias Therapeutics, Inc. — PartnerFacts page ↗

Sources

Form D/A · Jan 5, 2018 ↗ (Jan 5, 2018)
Vitruvias Therapeutics, Inc. — PartnerFacts page ↗ (Jan 5, 2018)

Note · Jun 11, 2021

Jason G. Wild appears on 1 deal that stopped filing before reaching its target

Webber Wild Impact Fund, LP (last filing Jun 11, 2021; $0 sold of $150,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Webber Wild Impact Fund, LP — PartnerFacts page ↗

Sources

Webber Wild Impact Fund, LP — PartnerFacts page ↗ (Jun 11, 2021)

Note · Oct 1, 1998 – Jan 27, 2025

No amendment in the last 12 months on an offering that may still be open — JW Select Investments, LP (latest filing Jan 27, 2025)

The latest filing for this offering is dated Jan 27, 2025 (first sale Oct 1, 1998). It reports $36,309,922 sold of an indefinite amount offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D/A · Jan 27, 2025 ↗JW Select Investments, LP — PartnerFacts page ↗

Sources

Form D/A · Jan 27, 2025 ↗ (Jan 27, 2025)
JW Select Investments, LP — PartnerFacts page ↗ (Jan 27, 2025)

Note · Jul 1, 2015 – Mar 15, 2024

No amendment in the last 12 months on an offering that may still be open — JW Opportunities Fund, Ltd. (latest filing Mar 15, 2024)

The latest filing for this offering is dated Mar 15, 2024 (first sale Jul 1, 2015). It reports $8,257,979 sold of an indefinite amount offered. No later amendment is in our index as of Oct 24, 2026.

Form D/A · Mar 15, 2024 ↗JW Opportunities Fund, Ltd. — PartnerFacts page ↗

Sources

Form D/A · Mar 15, 2024 ↗ (Mar 15, 2024)
JW Opportunities Fund, Ltd. — PartnerFacts page ↗ (Mar 15, 2024)

Note · Nov 21, 2016 – Dec 5, 2016

No amendment in the last 12 months on an offering that may still be open — Vensun Pharmaceuticals, Inc. (latest filing Dec 5, 2016)

The latest filing for this offering is dated Dec 5, 2016 (first sale Nov 21, 2016). It reports $19,499,991 sold of $22,499,979 offered. No later amendment is in our index as of Oct 24, 2026.

Form D · Dec 5, 2016 ↗Vensun Pharmaceuticals, Inc. — PartnerFacts page ↗

Sources

Form D · Dec 5, 2016 ↗ (Dec 5, 2016)
Vensun Pharmaceuticals, Inc. — PartnerFacts page ↗ (Dec 5, 2016)

Note · Jul 18, 2016 – Dec 18, 2017

Minimum investment changed between filings — JW Select Investments, LP

The Jul 18, 2016 filing lists a minimum of $5,000; the Dec 18, 2017 Form D/A lists $500,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D/A (earlier) · Jul 18, 2016 ↗Form D/A (later) · Dec 18, 2017 ↗JW Select Investments, LP — PartnerFacts page ↗

Sources

Form D/A (earlier) · Jul 18, 2016 ↗ (Jul 18, 2016)
Form D/A (later) · Dec 18, 2017 ↗ (Dec 18, 2017)
JW Select Investments, LP — PartnerFacts page ↗ (Jan 27, 2025)

Note · Jul 18, 2016 – Jul 17, 2017

Minimum investment changed between filings — JW Opportunities Fund, LLC

The Jul 18, 2016 filing lists a minimum of $250,000; the Jul 17, 2017 Form D/A lists $25,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D/A (earlier) · Jul 18, 2016 ↗Form D/A (later) · Jul 17, 2017 ↗JW Opportunities Fund, LLC — PartnerFacts page ↗

Sources

Form D/A (earlier) · Jul 18, 2016 ↗ (Jul 18, 2016)
Form D/A (later) · Jul 17, 2017 ↗ (Jul 17, 2017)
JW Opportunities Fund, LLC — PartnerFacts page ↗ (Mar 17, 2026)

Note · Jul 18, 2016 – Jul 17, 2017

Minimum investment changed between filings — JW Opportunities Fund, Ltd.

The Jul 18, 2016 filing lists a minimum of $500,000; the Jul 17, 2017 Form D/A lists $40,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Jul 18, 2016 ↗Form D/A (later) · Jul 17, 2017 ↗JW Opportunities Fund, Ltd. — PartnerFacts page ↗

Sources

Form D (earlier) · Jul 18, 2016 ↗ (Jul 18, 2016)
Form D/A (later) · Jul 17, 2017 ↗ (Jul 17, 2017)
JW Opportunities Fund, Ltd. — PartnerFacts page ↗ (Mar 15, 2024)

Note · Nov 3, 2010 – Dec 5, 2016

Jason G. Wild is written 2 different ways on the filings

listed as "Jason G. WIld" on 44 filings (from Nov 3, 2010), and "Jason Wild" on 26 filings (from Dec 5, 2016).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D/A · Nov 3, 2010 ↗Form D · Dec 5, 2016 ↗Jason G. Wild — PartnerFacts page ↗

Sources

Note · Dec 30, 2013 – Jul 16, 2015

Reported net asset value range changed between filings — JW Opportunities Fund, LLC

"Decline to Disclose" (Dec 30, 2013); then "$5,000,001 - $25,000,000" (Jul 16, 2014); then "Decline to Disclose" (Jul 16, 2015).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Dec 30, 2013 ↗Form D/A · Jul 16, 2014 ↗Form D/A · Jul 16, 2015 ↗JW Opportunities Fund, LLC — PartnerFacts page ↗

Sources

Form D · Dec 30, 2013 ↗ (Dec 30, 2013)
Form D/A · Jul 16, 2014 ↗ (Jul 16, 2014)
Form D/A · Jul 16, 2015 ↗ (Jul 16, 2015)
JW Opportunities Fund, LLC — PartnerFacts page ↗ (Mar 17, 2026)

Note · Nov 12, 2010 – Jul 16, 2015

Reported net asset value range changed between filings — JW Partners, LP

"Decline to Disclose" (Nov 12, 2010); then "Over $100,000,000" (Jul 16, 2013); then "Decline to Disclose" (Jul 16, 2015).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D/A · Nov 12, 2010 ↗Form D/A · Jul 16, 2013 ↗Form D/A · Jul 16, 2015 ↗JW Partners, LP — PartnerFacts page ↗

Sources

Form D/A · Nov 12, 2010 ↗ (Nov 12, 2010)
Form D/A · Jul 16, 2013 ↗ (Jul 16, 2013)
Form D/A · Jul 16, 2015 ↗ (Jul 16, 2015)
JW Partners, LP — PartnerFacts page ↗ (Mar 17, 2026)

Note · Nov 3, 2010 – Jul 16, 2015

Reported net asset value range changed between filings — JW Select Investments, LP

"Decline to Disclose" (Nov 3, 2010); then "$25,000,001 - $50,000,000" (Jul 16, 2013); then "$50,000,001 - $100,000,000" (Jul 16, 2014); then "Decline to Disclose" (Jul 16, 2015).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D/A · Nov 3, 2010 ↗Form D/A · Jul 16, 2013 ↗Form D/A · Jul 16, 2014 ↗Form D/A · Jul 16, 2015 ↗

Sources

Form D/A · Nov 3, 2010 ↗ (Nov 3, 2010)
Form D/A · Jul 16, 2013 ↗ (Jul 16, 2013)
Form D/A · Jul 16, 2014 ↗ (Jul 16, 2014)
Form D/A · Jul 16, 2015 ↗ (Jul 16, 2015)
JW Select Investments, LP — PartnerFacts page ↗ (Jan 27, 2025)

Note · May 30, 2019 – Jul 8, 2026

Same name, different state: "Jason Wild" (A6) is a separate record

This page covers filings where the address state is NC or NY or PA or FL. A separate record, "Jason Wild" with address state A6, is listed on 11 filings — most recently by TerrAscend Corp. (Jul 8, 2026). Both records have filings in the same period (May 30, 2019 to Mar 15, 2021).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Jason Wild (A6) — PartnerFacts page ↗Form D · Jul 8, 2026 ↗TerrAscend Corp. — PartnerFacts page ↗Jason G. Wild (NC,NY,PA,FL) — this page ↗

Sources

Jason Wild (A6) — PartnerFacts page ↗ (Jul 8, 2026)
Form D · Jul 8, 2026 ↗ (Jul 8, 2026)
TerrAscend Corp. — PartnerFacts page ↗ (Jul 8, 2026)
Jason G. Wild (NC,NY,PA,FL) — this page ↗ (Mar 15, 2021)

Note · Dec 20, 2017 – Mar 15, 2024

11 address changes between filings

Address moved from Armonk, NY to Miami Beach, FL — JW Growth Fund, LLC · Address moved from Armonk, NY to Miami Beach, FL — JW Opportunities Fund, LLC · Address moved from Armonk, NY to Miami Beach, FL — JW Partners, LP · Address moved from Armonk, NY to Miami Beach, FL — JW Opportunities Fund, Ltd. · Address moved from Armonk, NY to Miami Beach, FL — JW Select Investments, LP · and 6 more

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D/A · Mar 15, 2023 ↗Form D/A · Mar 15, 2024 ↗JW Growth Fund, LLC — PartnerFacts page ↗Form D/A · Mar 15, 2023 ↗

Sources

Form D/A · Mar 15, 2023 ↗ (Mar 15, 2023)
Form D/A · Mar 15, 2024 ↗ (Mar 15, 2024)
JW Growth Fund, LLC — PartnerFacts page ↗ (Mar 17, 2026)
Form D/A · Mar 15, 2023 ↗ (Mar 15, 2023)
Form D/A · Mar 15, 2024 ↗ (Mar 15, 2024)
JW Opportunities Fund, LLC — PartnerFacts page ↗ (Mar 17, 2026)
Form D/A · Mar 15, 2023 ↗ (Mar 15, 2023)
Form D/A · Mar 15, 2024 ↗ (Mar 15, 2024)

Note · Nov 3, 2010 – Mar 17, 2026

Jason G. Wild is listed with 3 different address states: NY, PA, FL

NY on 57 filings (Nov 3, 2010 to Mar 15, 2023); PA on 1 filing (Dec 5, 2016); FL on 12 filings (Jan 26, 2024 to Mar 17, 2026).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D/A · Nov 3, 2010 ↗Form D · Dec 5, 2016 ↗Form D/A · Jan 26, 2024 ↗

Sources

Form D/A · Nov 3, 2010 ↗ (Nov 3, 2010)
Form D · Dec 5, 2016 ↗ (Dec 5, 2016)
Form D/A · Jan 26, 2024 ↗ (Jan 26, 2024)

What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 78 filings (work cap); older filings are not covered here. As of Oct 24, 2026.

5. Money to insiders

4 of 16 offerings report sales commissions totalling $2,516,314; 0 report finder's fees; 4 report proceeds to related persons totalling $2,144,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)	Sales commissions	Finder's fees	To insiders	Paid to sell it	Source
Mar 17, 2026 D/A JW Partners, LP File 021-150452	$0	$0	$0	None listed on this filing	EDGAR ↗
Mar 17, 2026 D/A JW Opportunities Fund, LLC File 021-208959	$1,117,566	$0	$0	Chardan Capital Markets, LLC BrokerCheck CRD 120128 ↗ Silver Leaf Partners, LLC BrokerCheck CRD 126694 ↗ FBN Securities, Inc. BrokerCheck CRD 18315 ↗	EDGAR ↗
Mar 17, 2026 D/A JW Growth Fund, LLC File 021-338949	$41,520	$0	$0 Customary advisory fees will be paid by the Issuer to the Investment Manager as provided for in the Issuer's offering materials.	Chardan Capital Markets, LLC BrokerCheck CRD 120128 ↗ Silver Leaf Partners, LLC BrokerCheck CRD 126694 ↗ FBN Securities, Inc. BrokerCheck CRD 18315 ↗	EDGAR ↗
Jan 27, 2025 D/A JW Select Investments, LP File 021-149946	$0	$0	$0	None listed on this filing	EDGAR ↗
Mar 15, 2024 D/A JW Opportunities Fund, Ltd. File 021-267224	$362,228	$0	$0	Silver Leaf Partners, LLC BrokerCheck CRD 126694 ↗	EDGAR ↗
Jun 11, 2021 D Webber Wild Impact Fund, LP File 021-402636	$0	$0	$0 Customary advisory fees will be paid by the Issuer to the Investment Manager as provided for in the Issuer's offering materials.	None listed on this filing	EDGAR ↗
Jan 5, 2018 D/A Vitruvias Therapeutics, Inc. File 021-301275	$0	$0	$1,510,000 (est.) Bryce Harvey owns the majority of interests in H2-Pharma,LLC, which loaned money to the issuer. $1,500,000 will be used to pay down principal of that loan. $10,000 will be used to pay H2 Pharma, officers & directors interest on loans made to Company.	None listed on this filing	EDGAR ↗
Dec 5, 2016 D Vensun Pharmaceuticals, Inc. File 021-275666	$995,000 (est.)	$0	$9,000 (est.)	Leerink Partners LLC BrokerCheck CRD 39011 ↗	EDGAR ↗
Oct 7, 2015 D Vensun Pharmaceuticals, Inc. File 021-248895	$0	$0	$0	None listed on this filing	EDGAR ↗
Oct 11, 2013 D Vensun Pharmaceuticals, Inc. File 021-204468	$0	$0	$0	None listed on this filing	EDGAR ↗
Aug 22, 2013 D JW DealFund II, LP File 021-201735	$0	$0	$0 Customary advisory fees are paid by the Issuer to the Management Company as provided for in the Issuer's offering materials.	John Daniel Bradley BrokerCheck CRD 28292 ↗ via Torreya Partners (CRD 16668 ↗)	EDGAR ↗
Mar 28, 2012 D Vensun Pharmaceuticals, Inc. File 021-175723	$0	$0	$0	None listed on this filing	EDGAR ↗
Dec 10, 2010 D ARBOR PHARMACEUTICALS INC File 021-151731	$0	$0	$0 (est.)	None listed on this filing	EDGAR ↗
Nov 8, 2010 D JW DealFund I, LP File 021-150185	$0	$0	$600,000 (est.) A fee will be paid to the management company of which Jason Wild is an employee and a carried interest fee will be paid to the General Partner of which Jason Wild is the Managing Member.	None listed on this filing	EDGAR ↗
Nov 3, 2010 D/A J WILD FUND LP File 021-46511	$0	$0	$0 Customary advisory fees are paid by the Issuer to the Investment Manager as provided for in the Issuer's offering materials.	None listed on this filing	EDGAR ↗
Apr 20, 2010 D ARBOR PHARMACEUTICALS INC File 021-140880	$0	$0	$25,000 (est.)	None listed on this filing	EDGAR ↗

How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 12

Every issuer that named Jason G. Wild on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Pooled Investment Fund · group: Group linked by Jason G. Wild

JW Opportunities Fund, LLC

Miami Beach, FL · Dec 30, 2013 → Mar 17, 2026 · 15 filings

Mar 17, 2026 · D/A · $168,553,195 sold of Indefinite · 302 investors · min. $25,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
Mar 17, 2025 · D/A · $165,382,209 sold of Indefinite · 302 investors · min. $25,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
Mar 15, 2024 · D/A · $165,342,209 sold of Indefinite · 301 investors · min. $25,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Mar 15, 2023 · D/A · $165,222,209 sold of Indefinite · 301 investors · min. $25,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
Mar 15, 2022 · D/A · $164,668,609 sold of Indefinite · 300 investors · min. $25,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
Mar 15, 2021 · D/A · $132,849,461 sold of Indefinite · 260 investors · min. $25,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
Jan 28, 2021 · D/A · $121,760,451 sold of Indefinite · 234 investors · min. $25,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
Jan 28, 2020 · D/A · $102,656,510 sold of Indefinite · 189 investors · min. $25,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
Jan 29, 2019 · D/A · $95,085,731 sold of Indefinite · 167 investors · min. $25,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
Jan 29, 2018 · D/A · $71,723,786 sold of Indefinite · 128 investors · min. $25,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
Jul 17, 2017 · D/A · $71,423,786 sold of Indefinite · 127 investors · min. $25,000 · role: Executive Officer (President and managing member of JW GP, LLC, the fund's Manager.) EDGAR ↗
Jul 18, 2016 · D/A · $68,598,786 sold of Indefinite · 118 investors · min. $250,000 · role: Executive Officer (President and managing member of JW GP, LLC, the fund's Manager.) EDGAR ↗
Jul 16, 2015 · D/A · $60,360,649 sold of Indefinite · 93 investors · min. $250,000 · role: Executive Officer (President and managing member of JW GP, LLC, the fund's Manager.) EDGAR ↗
Jul 16, 2014 · D/A · $10,932,000 sold of Indefinite · 23 investors · min. $250,000 · role: Executive Officer (President and managing member of JW GP, LLC, the fund's Manager.) EDGAR ↗
Dec 30, 2013 · D · $3,625,000 sold of Indefinite · 7 investors · min. $250,000 · role: Executive Officer (President and managing member of JW GP, LLC, the fund's Manager.) EDGAR ↗

Raised $168.6M from 302 investors as of the latest filing. Jason is listed as executive officer on 15 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Group linked by Jason G. Wild

JW Partners, LP

Miami Beach, FL · Nov 12, 2010 → Mar 17, 2026 · 18 filings

Mar 17, 2026 · D/A · $96,017,769 sold of Indefinite · 94 investors · min. $5,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Mar 17, 2025 · D/A · $95,466,508 sold of Indefinite · 93 investors · min. $5,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Mar 15, 2024 · D/A · $95,319,343 sold of Indefinite · 93 investors · min. $5,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Mar 15, 2023 · D/A · $94,093,343 sold of Indefinite · 93 investors · min. $5,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Mar 15, 2022 · D/A · $93,354,311 sold of Indefinite · 93 investors · min. $5,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Mar 15, 2021 · D/A · $90,171,643 sold of Indefinite · 93 investors · min. $5,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jan 28, 2021 · D/A · $90,109,143 sold of Indefinite · 93 investors · min. $5,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jan 28, 2020 · D/A · $89,474,114 sold of Indefinite · 198 investors · min. $5,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jan 29, 2019 · D/A · $88,290,614 sold of Indefinite · 194 investors · min. $5,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jan 29, 2018 · D/A · $86,450,614 sold of Indefinite · 191 investors · min. $5,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jul 17, 2017 · D/A · $86,050,614 sold of Indefinite · 191 investors · min. $5,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jul 18, 2016 · D/A · $85,063,114 sold of Indefinite · 191 investors · min. $5,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jul 16, 2015 · D/A · $80,629,931 sold of Indefinite · 191 investors · min. $5,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jul 16, 2014 · D/A · $53,767,782 sold of Indefinite · 189 investors · min. $5,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jul 16, 2013 · D/A · $47,427,377 sold of Indefinite · 179 investors · min. $100,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jul 16, 2012 · D/A · $40,206,752 sold of Indefinite · 156 investors · min. $500,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Sep 29, 2011 · D/A · $37,880,591 sold of Indefinite · 148 investors · min. $500,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Nov 12, 2010 · D/A · $36,402,045 sold of Indefinite · 136 investors · min. $500,000 · role: Executive Officer (President & Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗

Raised $96M from 198 investors as of the latest filing. Jason is listed as executive officer on 18 filings for this deal.

Latest filing on EDGAR ↗

Sources

Pooled Investment Fund · group: Group linked by Jason G. Wild

JW Growth Fund, LLC

Miami Beach, FL · May 7, 2019 → Mar 17, 2026 · 8 filings

Mar 17, 2026 · D/A · $15,220,327 sold of Indefinite · 55 investors · min. $500,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
Mar 17, 2025 · D/A · $15,220,327 sold of Indefinite · 55 investors · min. $500,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
Mar 15, 2024 · D/A · $15,220,327 sold of Indefinite · 55 investors · min. $500,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
Mar 15, 2023 · D/A · $15,220,327 sold of Indefinite · 55 investors · min. $500,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
May 6, 2022 · D/A · $15,220,327 sold of Indefinite · 55 investors · min. $500,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
May 7, 2021 · D/A · $12,720,000 sold of Indefinite · 52 investors · min. $500,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
May 7, 2020 · D/A · $11,420,000 sold of Indefinite · 47 investors · min. $500,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗
May 7, 2019 · D · $0 sold of Indefinite · 0 investors · min. $500,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the Manager of the Issuer.) EDGAR ↗

Raised $15.2M from 55 investors as of the latest filing. Jason is listed as executive officer on 8 filings for this deal.

Latest filing on EDGAR ↗

Sources

Pooled Investment Fund · group: Group linked by Jason G. Wild

JW Select Investments, LP

Miami Beach, FL · Nov 3, 2010 → Jan 27, 2025 · 16 filings

Jan 27, 2025 · D/A · $36,309,922 sold of Indefinite · 98 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jan 26, 2024 · D/A · $36,309,922 sold of Indefinite · 98 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jan 27, 2023 · D/A · $36,309,922 sold of Indefinite · 98 investors · min. $500,000 · role: Executive Officer (President and Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jan 28, 2022 · D/A · $36,309,922 sold of Indefinite · 98 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jan 28, 2021 · D/A · $23,860,445 sold of Indefinite · 98 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Oct 7, 2020 · D/A · $13,040,445 sold of Indefinite · 67 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Oct 7, 2019 · D/A · $3,415,445 sold of Indefinite · 39 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Dec 18, 2017 · D/A · $2,287,938 sold of Indefinite · 39 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jul 18, 2016 · D/A · $887,938 sold of Indefinite · 23 investors · min. $5,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jul 16, 2015 · D/A · $887,938 sold of Indefinite · 23 investors · min. $5,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jul 16, 2014 · D/A · $887,938 sold of Indefinite · 23 investors · min. $5,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jul 16, 2013 · D/A · $829,966 sold of Indefinite · 23 investors · min. $5,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Jul 16, 2012 · D/A · $829,966 sold of Indefinite · 23 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Sep 29, 2011 · D/A · $829,966 sold of Indefinite · 23 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Nov 3, 2010 · D/A · $829,966 sold of Indefinite · 23 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗
Nov 3, 2010 · D/A · $829,966 sold of Indefinite · 12 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗

Raised $36.3M from 98 investors as of the latest filing. Jason is listed as executive officer on 16 filings for this deal.

Latest filing on EDGAR ↗

Sources

Pooled Investment Fund · group: Group linked by Jason G. Wild

JW Opportunities Fund, Ltd.

Miami Beach, FL · Jul 18, 2016 → Mar 15, 2024 · 10 filings

Mar 15, 2024 · D/A · $8,257,979 sold of Indefinite · 9 investors · min. $40,000 · role: Director EDGAR ↗
Mar 15, 2023 · D/A · $8,257,979 sold of Indefinite · 9 investors · min. $40,000 · role: Director EDGAR ↗
Mar 15, 2022 · D/A · $8,257,979 sold of Indefinite · 9 investors · min. $40,000 · role: Director EDGAR ↗
Mar 15, 2021 · D/A · $8,257,979 sold of Indefinite · 9 investors · min. $40,000 · role: Director EDGAR ↗
Jan 28, 2021 · D/A · $7,757,979 sold of Indefinite · 8 investors · min. $40,000 · role: Director EDGAR ↗
Jan 28, 2020 · D/A · $7,757,979 sold of Indefinite · 10 investors · min. $40,000 · role: Director EDGAR ↗
Jan 29, 2019 · D/A · $1,457,979 sold of Indefinite · 8 investors · min. $40,000 · role: Director EDGAR ↗
Jan 29, 2018 · D/A · $1,350,000 sold of Indefinite · 6 investors · min. $40,000 · role: Director EDGAR ↗
Jul 17, 2017 · D/A · $1,550,000 sold of Indefinite · 9 investors · min. $40,000 · role: Director EDGAR ↗
Jul 18, 2016 · D · $1,350,000 sold of Indefinite · 9 investors · min. $500,000 · role: Director EDGAR ↗

Raised $8.26M from 10 investors as of the latest filing. Jason is listed as director on 10 filings for this deal.

Latest filing on EDGAR ↗

Sources

Pooled Investment Fund

Webber Wild Impact Fund, LP

Armonk, NY · Jun 11, 2021

Jun 11, 2021 · D · $0 sold of $150,000,000 · 0 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗

No sales reported yet as of the latest filing. Jason is listed as executive officer.

Latest filing on EDGAR ↗

Sources

Pharmaceuticals

Vitruvias Therapeutics, Inc.

Auburn, AL · Jan 5, 2018

Jan 5, 2018 · D/A · $11,500,000 sold of $11,500,000 · 23 investors · min. $25,000 · role: Director (Upon consummation of stock purchase transaction, he became a director.) EDGAR ↗

Raised $11.5M from 23 investors (100% of the $11.5M target) as of the latest filing. Jason is listed as director.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals · group: Vensun Pharmaceuticals

Vensun Pharmaceuticals, Inc.

Yardley, PA · Mar 28, 2012 → Dec 5, 2016 · 4 filings

Dec 5, 2016 · D · $19,499,991 sold of $22,499,979 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
Oct 7, 2015 · D · $4,000,000 sold of $16,000,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
Oct 11, 2013 · D · $10,669,998 sold of $15,809,999 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
Mar 28, 2012 · D · $5,708,000 sold of $5,708,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $19.5M from 15 investors (87% of the $22.5M target) as of the latest filing. Jason is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Jw Dealfund

JW DealFund II, LP

New York, NY · Aug 22, 2013

Aug 22, 2013 · D · $0 sold of $15,000,000 · 0 investors · min. $500,000 · role: Executive Officer, Promoter (President and Mananging Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗

No sales reported yet as of the latest filing. Jason is listed as executive officer, promoter.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Pharmaceuticals

ARBOR PHARMACEUTICALS INC

Atlanta, Georgia (as filed: 2Q) · Apr 20, 2010 → Dec 10, 2010 · 2 filings

Dec 10, 2010 · D · $17,415,000 sold of $17,415,000 · 10 investors · min. $1 · role: Executive Officer, Director EDGAR ↗
Apr 20, 2010 · D · $4,600,000 sold of $4,600,000 · 7 investors · min. $1 · role: Executive Officer, Director EDGAR ↗

Raised $17.4M from 10 investors (100% of the $17.4M target) as of the latest filing. Jason is listed as executive officer, director on 2 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Pooled Investment Fund · group: Jw Dealfund

JW DealFund I, LP

New York, NY · Nov 8, 2010

Nov 8, 2010 · D · $5,440,000 sold of $30,000,000 · 46 investors · min. $10,000 · role: Executive Officer (Managing Member of General Partner of Issuer) EDGAR ↗

Raised $5.44M from 46 investors (18% of the $30M target) as of the latest filing. Jason is listed as executive officer.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Pooled Investment Fund · group: Jw Dealfund

J WILD FUND LP

New York, NY · Nov 3, 2010

Nov 3, 2010 · D/A · $4,177,000 sold of Indefinite · 8 investors · min. $500,000 · role: Executive Officer (President and Senior Managing Member of JW GP, LLC, the General Partner of the Issuer.) EDGAR ↗

Raised $4.18M from 8 investors as of the latest filing. Jason is listed as executive officer.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

Jason Wild — Ontario, Canada (as filed: A6), 1 issuer, May 30, 2019 → Jul 8, 2026 · no shared issuer

People around Jason 20

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

Management entity